Bayer faces second trial over alleged Roundup cancer risk

(Reuters) – Bayer AG is set to face a second U.S. jury over allegations that its popular glyphosate-based weed killer Roundup causes cancer, six months after the company’s share price was rocked by a $289 million verdict in California state court.

FILE PHOTO: A woman uses a Monsanto’s Roundup weedkiller spray without glyphosate in a garden in Ercuis near Paris, France, May 6, 2018. REUTERS/Benoit Tessier/File Photo

A lawsuit by California resident Edwin Hardeman against the company was scheduled to begin on Monday in federal rather than state court. The trial is also a test case for a larger litigation. More than 760 of the 9,300 Roundup cases nationwide are consolidated in the federal court in San Francisco that is hearing Hardeman’s case.

Bayer denies all allegations that Roundup or glyphosate cause cancer, saying decades of independent studies have shown the world’s most widely used weed killer to be safe for human use and noting that regulators around the world have approved the product.

Under a January ruling by U.S. District Judge Vince Chhabria, who presides over the federal litigation, jurors in Hardeman’s case will not initially hear all the evidence presented in last year’s California trial.

Chhabria called evidence by plaintiffs that the company allegedly attempted to influence regulators and manipulate public opinion “a distraction” from the science in the cases. He said such evidence should only go before the jury in a second trial phase that would only take place if they determined Roundup caused Hardeman’s cancer.

Evidence of corporate misconduct was seen as playing a key role in the finding by a California state court jury in August that Roundup caused another man’s non-Hodgkin’s lymphoma and that Bayer’s Monsanto unit failed to warn consumers about the weed killer’s cancer risks. That jury’s $289 million damages award was later reduced to $78 million.

Bayer’s share price dropped 10 percent following the verdict and has remained volatile.

Hardeman began using the Roundup brand herbicide with glyphosate in the 1980s to control poison oak and weeds on his property and sprayed “large volumes” of the chemical for many years on a regular basis, according to court documents. He was diagnosed with non-Hodgkin’s lymphoma, a cancer of the lymph system, in February 2015 and filed his lawsuit a year later.

But Hardeman has a history of hepatitis C, a risk factor for developing lymphoma. Bayer in court filings also said the majority of non-Hodgkin’s lymphoma incidents are idiopathic, or have no known cause.

Plaintiffs criticized Chhabria’s order dividing the trial and restricting evidence as “unfair,” saying their scientific evidence allegedly showing glyphosate causes cancer is inextricably linked to Monsanto’s alleged wrongful conduct.

Reporting by Tina Bellon in New York; Editing by Cynthia Osterman and Jonathan Oatis

Source

more recommended stories

  • Bayer, J&J settle thousands of U.S. Xarelto lawsuits for $775 million

    (Reuters) – Bayer AG and Johnson.

  • Texas petrochemical fire prompts hundreds to visit health clinic

    DEER PARK, Texas (Reuters) – Hundreds.

  • U.S. Customs details China pork seizure; importers could pay fine

    CHICAGO (Reuters) – U.S. border agents.

  • FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes

    (Reuters) – The U.S. Food and.

  • Tyson recalls tons of chicken strips for possible metal contamination

    (Reuters) – Tyson Foods Inc is.

  • Mississippi governor signs ‘heartbeat’ abortion ban

    (Reuters) – Mississippi’s Republican governor signed.

  • Congo Ebola outbreak spreads to city of Bunia

    GOMA, Democratic Republic of Congo (Reuters).

  • Second U.S. jury finds Bayer’s Roundup caused cancer

    (Reuters) – A U.S. jury on.

  • Soda, sports drinks tied to higher risk of early death

    (Reuters Health) – People who consume.

  • Apple Watch detects irregular heart beat in large U.S. study

    (Reuters) – The Apple Watch was.

  • Edwards, Medtronic heart valve systems prove worth in low-risk patients -studies

    (Reuters) – Non-invasive heart valve replacement.

  • U.S. seizes 1 million pounds of pork from China on swine fever concerns

    WASHINGTON (Reuters) – U.S. border agents.

  • Teen drivers reaching for objects more likely to crash

    (Reuters Health) – Teen drivers who.

  • Quality of surgical care across a hospital network may vary

    (Reuters Health) – Just because the.

  • California jury awards $29 million to woman with cancer who used J&J talc

    (Reuters) – A California jury on.

  • As wildfires devour communities, toxic threats emerge

    PARADISE, Calif. (Reuters) – As an.

  • Court allows Ohio law blocking Planned Parenthood funding

    FILE PHOTO: A sign is pictured.

  • FDA approves Pfizer’s biosimilar to Roche’s Herceptin

    FILE PHOTO: The logo of U.S..

  • Mumps, other outbreaks force U.S. detention centres to quarantine over 2,000 migrants

    (Reuters) – Christian Mejia thought he.

  • Measles outbreak in New Zealand’s Canterbury widens to 20

    MELBOURNE (Reuters) – Thousands of vaccines.

  • OxyContin maker Purdue Pharma loses bid to delay opioid epidemic trial

    (Reuters) – OxyContin maker Purdue Pharma.

  • Roche’s Tecentriq wins U.S. approval for aggressive breast cancer

    FILE PHOTO: The logo of Swiss.

  • Knee surgery for torn cartilage may not be worthwhile

    (Reuters Health) – Many middle-aged and.

  • FDA finds asbestos in three Claire’s cosmetics products

    (Reuters) – The U.S. Food and.

  • J&J nasal spray gets U.S. approval as first new type of anti-depressant in decades

    (Reuters) – The U.S. Food and.

  • London HIV patient becomes world’s second AIDS cure hope

    LONDON, March 4 (Reuters) – An.

  • Eli Lilly seeks to quell drug price anger with cheaper insulin

    (Reuters) – Drugmaker Eli Lilly announced.

  • Ebola treatment centre in Congo reopens after attack – ministry

    KINSHASA (Reuters) – An Ebola treatment.

  • Quebec appeals court upholds C$15 billion tobacco class action ruling

    MONTREAL/LONDON (Reuters) – The Court of.

  • Gastric bypass surgery tied to diabetes remission

    (Reuters Health) – Three in four.

  • After attacks, MSF suspends Ebola treatment in epicenter of Congo outbreak

    DAKAR (Reuters) – Medecins Sans Frontieres.

  • Yoga linked to lowered blood pressure with regular practice

    (Reuters Health) – Adults who practice.